Myxoid Liposarcomas of the Thigh: Pre-Operative Presentation, Clinical Outcomes, and Functional Results of Surgical Treatment
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Muratori, F.; Bettini, L.; Frenos, F.; Mondanelli, N.; Greto, D.; Livi, L.; Franchi, A.; Roselli, G.; Scorianz, M.; Capanna, R.; et al. Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution. Int. J. Surg. Oncol. 2018, 16, 8928706. [Google Scholar] [CrossRef] [PubMed]
- Sbaraglia, M.; Bellan, E.; Dei Tos, A.P. The 2020 WHO Classification of Soft Tissue Tumours: News and perspectives. Pathologica 2021, 113, 70–84. [Google Scholar] [CrossRef]
- Amer, K.M.; Congiusta, D.V.; Thomson, J.E.; Elsamna, S.; Chaudhry, I.; Bozzo, A.; Amer, R.; Siracuse, B.; Ghert, M.; Beebe, K.S. Epidemiology and survival of liposarcoma and its subtypes: A dual database analysis. J. Clin. Orthop. Trauma 2020, 11 (Suppl. S4), S479–S484. [Google Scholar] [CrossRef] [PubMed]
- Tfayli, Y.; Baydoun, A.; Naja, A.S.; Saghieh, S. Management of myxoid liposarcoma of the extremity. Oncol. Lett. 2021, 22, 596. [Google Scholar] [CrossRef] [PubMed]
- Chowdhry, V.; Goldberg, S.; DeLaney, T.F.; Cote, G.M.; Chebib, I.; Kim, J.; Lozano-Calderon, S.A.; Berstein, K.D.A. Myxoid Liposarcoma: Treatment Outcomes from Chemotherapy and Radiation Therapy. Sarcoma 2018, 2018, 8029157. [Google Scholar] [CrossRef] [PubMed]
- Gronchi, A.; Miah, A.B.; Dei Tos, A.P.; Bajpai, J.; Bauer, S. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2021, 32, 1348–1365. [Google Scholar] [CrossRef]
- Gronchi, A.; Palmerini, E.; Quagliuolo, V.; Pousa, A.; Grignani, G.; Casali, P.G. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG). J. Clin. Oncol. 2024, 42, 2838. [Google Scholar] [CrossRef]
- Schulte, B.; Mach, N.; Olivier, T. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcomas: Looking Forward to What Is Next. J. Clin. Oncol. 2024, 42, 2488. [Google Scholar] [CrossRef]
- Lansu, J.; Van Houdt, W.J.; Schaapveld, M.; Walraven, I.; Van de Sande, M.A.J.; Ho, V.K.Y.; Haas, R.L. Time Trends and Prognostic Factors for Overall Survival in Myxoid Liposarcomas: A Population-Based Study. Sarcoma 2020, 22, 2437850. [Google Scholar] [CrossRef]
- Abaricia, S.; Hirbe, A.C. Diagnosis and Treatment of Myxoid Liposarcomas: Histology Matters. Curr. Treat. Options Oncol. 2018, 19, 64. [Google Scholar] [CrossRef]
- Soomers, V.; Husson, O.; Young, R.; Desar, I.; Van der Graaf, W. The sarcoma diagnostic interval: A systematic review on length, contributing factors and patient outcomes. ESMO Open. 2020, 5, e000592. [Google Scholar] [CrossRef]
- Brouns, F.; Stas, M.; De Wever, I. Delay in diagnosis of soft tissue sarcomas. Eur. J. Surg. Oncol. 2003, 29, 440–445. [Google Scholar] [CrossRef]
- George, A.; Grimer, R. Early symptoms of bone and soft tissue sarcomas: Could they be diagnosed earlier? Ann. R Coll. Surg. Engl. 2012, 94, 261–266. [Google Scholar] [CrossRef] [PubMed]
- El Ouni, F.; Jemni, H.; Trabelsi, A.; Ben Maitig, M.; Arifa, N.; Ben Rhouma, K.; Ben Ayech, M.; Tlili, K. Liposarcoma of the extremities: MR imaging features and their correlation with pathologic data. Orthop. Traumatol. Surg. Res. 2010, 96, 876–883. [Google Scholar] [CrossRef]
- Walker, J.B.; Stockwell, E.; Worhacz, K.; Kang, P.; Decomas, A. Safety and Accuracy of Core Needle Biopsy for Soft Tissue Masses in an Ambulatory Setting. Sarcoma 2018, 2018, 1657864. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.Y.; Chung, H.W.; Oh, T.S.; Lee, J.S. Practical Guidelines for Ultrasound-Guided Core Needle Biopsy of Soft-Tissue Lesions: Transformation from Beginner to Specialist. Korean J. Radiol. 2017, 18, 361–369. [Google Scholar] [CrossRef] [PubMed]
- Mavrogenis, A.F.; Altsitzioglou, P.; Tsukamoto, S.; Errani, C. Biopsy Techniques for Musculoskeletal Tumors: Basic Principles and Specialized Techniques. Curr. Oncol. 2024, 31, 900–917. [Google Scholar] [CrossRef]
- Deacu, M.; Bosoteanu, M.; Enciu, M.; Cozaru, G.C.; Cojocaru, O.; Baltatescu, G.I.; Nicolau, A.A.; Orasanu, C.I.; Caraban, B.M.; Voda, R.I. The Predictive Role of the Histopathological Scoring System in Adipose Tumors-Lipoma, Atypical Lipomatous Tumor, and Liposarcoma. Diagnostics 2023, 13, 3606. [Google Scholar] [CrossRef] [PubMed]
- Nakayama, R.; Mori, T.; Okita, Y.; Shiraishi, Y.; Endo, M. A multidisciplinary approach to soft-tissue sarcoma of the extremities. Expert. Rev. Anticancer. Ther. 2020, 20, 893–900. [Google Scholar] [CrossRef]
- Engström, K.; Bergh, P.; Gustafson, P.; Hultborn, R.; Johansson, H.; Löfvenberg, R.; Zaikova, O.; Trovik, C.; Wahlström, O.; Bauer, H.C.F. Liposarcoma: Outcome based on the Scandinavian Sarcoma Group register. Cancer 2008, 113, 1649–1656. [Google Scholar] [CrossRef]
- Lemeur, M.; Mattei, J.C.; Souteyrand, P.; Chagnaud, C.; Curvale, G.; Rochwerger, A. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up. Orthop. Traumatol. Surg. Res. 2015, 101, 103–107. [Google Scholar] [CrossRef] [PubMed]
- Kilpatrick, S.E.; Doyon, J.; Choong, P.F.; Sim, F.H.; Nascimento, A.G. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996, 77, 1450–1458. [Google Scholar] [CrossRef]
- Fiore, M.; Grosso, F.; Lo Vullo, S.; Pennacchioli, E.; Stacciotti, S.; Ferrari, A.; Collini, P.; Lozza, L.; Mariani, L.; Casali, P.G.; et al. Myxoid/round cell and pleomorphic liposarcomas: Prognostic factors and survival in a series of patients treated at a single institution. Cancer 2007, 109, 2522–2531. [Google Scholar] [CrossRef]
- Sambri, A.; Caldari, E.; Fiore, M.; Zucchini, R.; Giannini, C.; Pirini, M.G.; Spinnato, P.; Cappelli, A.; Donati, D.M.; De Paolis, M. Margin Assessment in Soft Tissue Sarcomas: Review of the Literature. Cancers 2021, 13, 1687. [Google Scholar] [CrossRef] [PubMed]
- Pignatti, G.; Campanacci, M. Surgical approach to soft tissue sarcomas of the extremities. Ann. Oncol. 1992, 3 (Suppl. S2), S59–S61. [Google Scholar] [CrossRef] [PubMed]
- Chao, A.H.; Mayerson, J.L.; Chandawarkar, R.; Scharschmidt, T.J. Surgical management of soft tissue sarcomas: Extremity sarcomas. J. Surg. Oncol. 2015, 111, 540–545. [Google Scholar] [CrossRef]
- Shah, A.; Ramanujan, V.; Muralidharan, K.; AnRaja, A. Outcomes of Vascular Resection and Reconstruction in Extremity Soft Tissue Sarcoma and Bone Tumors. Vasc. Specialist. Int. 2021, 37, 22–28. [Google Scholar] [CrossRef]
- Tuzzato, G.; Laranga, R.; Ostetto, F.; Bubbico, E.; Vara, G.; Bianchi, G. Primary High-Grade Myxoid Liposarcoma of the Extremities: Prognostic Factors and Metastatic Pattern. Cancers 2022, 14, 2657. [Google Scholar] [CrossRef]
- Tanaka, A.; Okamoto, M.; Kito, M.; Yoshimura, Y.; Aoki, K.; Suzuki, S.; Takazawa, A.; Komatsu, Y.; Ideta, H.; Ishida, T.; et al. Muscle strength and functional recovery for soft-tissue sarcoma of the thigh: A prospective study. Int. J. Clin. Oncol. 2023, 28, 922–927. [Google Scholar] [CrossRef]
- Wiffen, J.; Mah, E. Determining functional outcomes after resection and reconstruction of primary soft tissue sarcoma in the lower extremity: A review of current subjective and objective measurement systems. J. Surg. Oncol. 2023, 127, 862–870. [Google Scholar] [CrossRef]
- Gu, X.; Ricketts, S.; Mah, E. Functional outcomes after single quadriceps muscle resection in patients with soft tissue sarcoma of the anterior compartment of the thigh. ANZ J. Surg. 2023, 93, 288–293. [Google Scholar] [CrossRef] [PubMed]
- Pavlidis, E.T.; Pavlidis, T.E. New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy. World J. Clin. Oncol. 2023, 14, 89–98. [Google Scholar] [CrossRef] [PubMed]
- Gabriele, L.; Gariffo, G.; Grossi, S.; Ipponi, E.; Capanna, R.; Andreani, L. Closed Incisional Negative Pressure Wound Therapy (ciNPWT) in Oncological Orthopedic Surgery: Preliminary Report. Surg. Technol. Int. 2021, 38, 451–454. [Google Scholar] [CrossRef] [PubMed]
- Campbell, S.R.; Wooley, J.R.; Nystrom, L.M. Modern Multidisciplinary Management of Soft Tissue Sarcoma of the Extremity and Trunk. JCO Oncol. Pract. 2024, 20, 907–914. [Google Scholar] [CrossRef]
- Forcina, L.; Cosentino, M.; Musarò, A. Mechanisms Regulating Muscle Regeneration: Insights into the Interrelated and Time-Dependent Phases of Tissue Healing. Cells 2020, 9, 1297. [Google Scholar] [CrossRef] [PubMed]
- Kask, G.; Repo, J.P.; Tukiainen, E.J.; Blomqvist, C.; Barner-Rasmussen, I. Soft Tissue Sarcoma of Lower Extremity: Functional Outcome and Quality of Life. Ann. Surg. Oncol. 2021, 28, 6892–6905. [Google Scholar] [CrossRef] [PubMed]
- Andrews, C.C.; Siegel, G.; Smith, S. Rehabilitation to Improve the Function and Quality of Life of Soft Tissue and Bony Sarcoma Patients. Patient. Relat. Outcome Meas. 2019, 10, 417–425. [Google Scholar] [CrossRef]
- Tobias, K.; Gillis, T. Rehabilitation of the sarcoma patient-enhancing the recovery and functioning of patients undergoing management for extremity soft tissue sarcomas. J. Surg. Oncol. 2015, 111, 615–621. [Google Scholar] [CrossRef]
- Tazreean, R.; Nelson, G.; Twomey, R. Early mobilization in enhanced recovery after surgery pathways: Current evidence and recent advancements. J. Comp. Eff. Res. 2022, 11, 121–129. [Google Scholar] [CrossRef]
Low-Grade (n = 20) | High-Grade (n = 10) | Total Population (n = 30) | p (<0.05) | |
---|---|---|---|---|
Number | 20 | 10 | 30 | - |
Mean Age (min–max) | 45.5 (17–71) | 56.7 (25–77) | 49.2 (17–77) | - |
Gender Female Male | 11 9 | 2 8 | 13 17 | - |
Average Diagnostic Interval (min–max) | 7.7 (1–16) | 7.5 (1–60) | 7.6 (1–60) | |
Localization Anterior Compartment Medial Compartment Posterior Compartment | 7 6 7 | 5 2 3 | 12 8 10 | - |
Mean Size (min–max) | 11.2 cm (5–18) | 13.2 cm (5–23) | 11.9 cm (5–23) | - |
Pre-Op Swelling (percentage) | 20 (100%) | 10 (100%) | 30 (100%) | - |
Pre-Op Pain (percentage) | 2 (10%) | 0 | 2 (7%) | - |
Mean Pre-Op MSTS Score (min–max) | 26.0 (15–29) | 25.2 (15–29) | 25.8 (15–29) | - |
Pre-Op Radiotherapy (percentage) | 0 | 8 (80%) | 9 (27%) | - |
Margins Wide Marginal | 16 4 | 8 2 | 24 6 | - |
Intra-Op Complications | 0 | 0 | 0 | - |
Post-Op Complications (percentage) Seroma Infection Dehiscence Dysesthesia | 4 (20%) 1 1 1 1 | 2 (20%) 1 1 0 0 | 6 (20%) 2 2 1 1 | - |
Post-Op Radiotherapy (percentage) | 3 (15%) | 0 | 3 (10%) | - |
Local Recurrences (percentage) | 4 (20%) | 1 (10%) | 5 (15%) | FISHER’S EXACT TEST: Contingency between low grade and local recurrence (p = 0.041) |
Metastases (percentage) | 0 | 3 (33%) | 3 (10%) | FISHER’S EXACT TEST: Contingency between high-grade lesions and metastases (p = 0.031) |
Oncological Outcomes CDF (percentage) DOC (percentage) NED (percentage) AWD (percentage) DOD (percentage) | 15 (75%) 0 3 (15%) 1 (5%) 1 (5%) | 5 (50%) 1 (10%) 2 (20%) 1 (10%) 1 (10%) | 21 (70%) 1 (3%) 5 (17%) 2 (7%) 1 (3%) | - |
Mean Post-Op MSTS Score (min–max) | 26.7 (15–30) | 27.6 (25–30) | 27.0 (15–30) | - |
Follow-Up (min–max) | 60.4 months (21–89) | 53.5 months (20–72) | 58.1 months (20–89) | - |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ipponi, E.; Bechini, E.; Cordoni, M.; Gentili, F.; Cosseddu, F.; D’Arienzo, A.; Andreani, L. Myxoid Liposarcomas of the Thigh: Pre-Operative Presentation, Clinical Outcomes, and Functional Results of Surgical Treatment. Healthcare 2024, 12, 1718. https://doi.org/10.3390/healthcare12171718
Ipponi E, Bechini E, Cordoni M, Gentili F, Cosseddu F, D’Arienzo A, Andreani L. Myxoid Liposarcomas of the Thigh: Pre-Operative Presentation, Clinical Outcomes, and Functional Results of Surgical Treatment. Healthcare. 2024; 12(17):1718. https://doi.org/10.3390/healthcare12171718
Chicago/Turabian StyleIpponi, Edoardo, Elena Bechini, Martina Cordoni, Fabrizia Gentili, Fabio Cosseddu, Antonio D’Arienzo, and Lorenzo Andreani. 2024. "Myxoid Liposarcomas of the Thigh: Pre-Operative Presentation, Clinical Outcomes, and Functional Results of Surgical Treatment" Healthcare 12, no. 17: 1718. https://doi.org/10.3390/healthcare12171718
APA StyleIpponi, E., Bechini, E., Cordoni, M., Gentili, F., Cosseddu, F., D’Arienzo, A., & Andreani, L. (2024). Myxoid Liposarcomas of the Thigh: Pre-Operative Presentation, Clinical Outcomes, and Functional Results of Surgical Treatment. Healthcare, 12(17), 1718. https://doi.org/10.3390/healthcare12171718